CANC vs VIG5YCANCCANCAvsBVIGVIGTema Oncology ETF · $217MVanguard Dividend Appreciation ETF · $109BReturns · dividends in+22.4%3 years · per year$18,348 · $16,806+18.9%[…]5 years · per year[…] · $16,596+10.7%Cost and income0.99%Expense ratio$99 · $4 on $10k · lower wins0.04%0.05%12-mo yield$5 · $145 on $10k1.45%
Overlap: CANC, VIG, SCHDToday14.5%most shared, VIG and SCHDCANCVIGSCHDCANC—11.9%8.4%VIG11.9%—14.5%SCHD8.4%14.5%—End-of-day Nov 12, 2026 · share held in common · outlined: the pair in versus
CANC vs VIG5YACANCTema Oncology[…]vsVIGBVanguard Dividend Appreciation$16,596MeasureCANCVIGFee0.99%0.04%Cost on $10k a year$99$4Yield0.05%1.45%5 years, per year[…]+10.7%3 years, per year+22.4%+18.9%Worst drop · 1Y−13.2%−7.9%Volatility · 1Y24.1%11.0%
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1BVIGVanguard Dividend Appreciation ETFReadDesk0.04%1.45%0.0%+16.0%+16.9%+18.9%+10.7%−7.9%$109.1B2SCHDSchwab U.S. Dividend Equity ETFReadDesk0.06%2.93%−0.2%+34.2%+36.8%+19.9%+10.4%−6.9%$122.7B3ACANCTema Oncology ETFReadDesk0.99%0.05%−2.6%+18.7%+25.5%+22.4%new−13.2%$217MEnd-of-day Nov 12, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1BVIGVanguard Dividend Appreciation ETFReadDesk0.04%1.45%0.0%+16.0%+16.9%+18.9%+10.7%−7.9%$109.1B2SCHDSchwab U.S. Dividend Equity ETFReadDesk0.06%2.93%−0.2%+34.2%+36.8%+19.9%+10.4%−6.9%$122.7B3ACANCTema Oncology ETFReadDesk0.99%0.05%−2.6%+18.7%+25.5%+22.4%new−13.2%$217MEnd-of-day Nov 12, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
DGRO vs VIGYTDiSharesDGROiSA+19.6%vsBVVIGVanguard+16.0%Jan 1Nov 12+19.6%+16.0%+19.6%Year to date+16.0%1.8%Yield1.4%$45.9BAssets$109B2–0DGRO winsEnd-of-day Nov 12, 2026
JEPQ vs JEPIYTDJ.P. MorganJEPQJMA+7.8%vsBJMJEPIJ.P. Morgan+8.3%Jan 1Nov 12+7.8%+8.3%+7.8%Year to date+8.3%12.2%Yield7.9%$41.8BAssets$46.8B1–1levelEnd-of-day Nov 12, 2026
SPYM vs SPYYTDSPDRSPYMSA+12.0%vsBSSPYSPDR+11.9%Jan 1Nov 12+12.0%+11.9%+12.0%Year to date+11.9%1.0%Yield1.0%$183BAssets$793B1–0SPYM winsEnd-of-day Nov 12, 2026
Overlap: CANC, VIG, SCHDToday14.5%most shared, VIG and SCHDCANCVIGSCHDCANC—11.9%8.4%VIG11.9%—14.5%SCHD8.4%14.5%—End-of-day Nov 12, 2026 · share held in common · outlined: the pair in versus
Income After Fees on $10,0001Y$287most kept, SCHDSCHD$293 − $6 = $287VIG$145 − $4 = $141CANC$5 − $99 = −$94KeptFeeEnd-of-day Nov 12, 2026 · yield in dollars minus the fee